Topical Tranexamic Acid on Donor Wounds in Burn Patients: A Randomized Placebo-controlled Trial
This study demonstrates that topical application of TXA (25 mg/mL) to split-thickness skin graft donor wounds does not delay re-epithelialization. Although a reduction in bleeding is suggested, further studies are needed to determine the role of topical TXA in reducing bleeding in burn surgery.
Authors
- Stian Kreken Almeland (ORCID: https://orcid.org/0000-0001-5992-4791)
- Olav Spigset (ORCID: https://orcid.org/0000-0001-7902-9014)
- Kjersti Ausen (ORCID: https://orcid.org/0000-0001-6247-5608)
- Håvard Nordgaard
- Ragnvald Ljones L Brekke
- Robert Norheim Colclough
- Hilde Pleym
Institutions
- Norwegian University of Science and Technology (NO)
- Haukeland University Hospital (NO)
- St Olav's University Hospital (NO)
- University of Bergen (NO)
Publication Details
- Journal
- Plastic & Reconstructive Surgery Global Open
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1097/gox.0000000000006074
- Citations
- 2
- Primary Topic
- Blood transfusion and management
- Type
- article
- Field-Weighted Citation Impact
- 0.45
Funders
- Pfizer
- Norges Teknisk-Naturvitenskapelige Universitet
- Helse Midt-Norge
- Faculty of Medicine and Health, University of Sydney